Ovoca Bio Investor Relations Material
Latest events
H1 2024
25 Sep, 2024
H2 2023
25 Jun, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ovoca Bio plc
Access all reports
Ovoca Bio plc is a clinical-stage biopharmaceutical company focusing on women's health. The company is actively involved in developing novel therapeutic products, particularly targeting female sexual dysfunction. Its lead candidate, a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, is under clinical development. Ovoca Bio's research and development efforts are geared towards addressing unmet medical needs in this area. The company is headquartered in Dublin, Ireland, and its shares are listed on the Euronext Dublin.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
OVXA
Country
🇮🇪 Ireland